MedPath

Ghent University Hospital

Ghent University Hospital logo
🇧🇪Belgium
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.uzgent.be

Clinical Trials

713

Active:80
Completed:414

Trial Phases

6 Phases

Early Phase 1:2
Phase 1:79
Phase 2:67
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (552 trials with phase data)• Click on a phase to view related trials

Not Applicable
315 (57.1%)
Phase 1
79 (14.3%)
Phase 4
71 (12.9%)
Phase 2
67 (12.1%)
Phase 3
18 (3.3%)
Early Phase 1
2 (0.4%)

The Pressure Relieving Capacity of Siliconepads Compared to Felted Foam to Relieve Caput Metatarsal 2 in a Population With Diabetes

Not yet recruiting
Conditions
Diabete Mellitus
Peripheral Neuropathy
First Posted Date
2025-09-15
Last Posted Date
2025-09-22
Lead Sponsor
University Hospital, Ghent
Target Recruit Count
80
Registration Number
NCT07172763

Comparing TCAF and MTUN With Soft Tissue Grafting for Treating Single Recessions in the Premandible

Not Applicable
Recruiting
Conditions
Gingival Recession, Localized
Gingival Recession, Mucogingival Surgery
Gingival Recession Localized Moderate
Gingival Recession
Gingival Recession, Plastic Surgery
First Posted Date
2025-09-08
Last Posted Date
2025-09-16
Lead Sponsor
University Hospital, Ghent
Target Recruit Count
24
Registration Number
NCT07158541
Locations
🇧🇪

Department of Periodontology and Implantology of Ghent University, Ghent, Oost-Vlaanderen, Belgium

Comparing CAF and TCAF With Soft Tissue Grafting for Treating Multiple Recessions in the Maxilla.

Not Applicable
Recruiting
Conditions
Gingival Recession Generalized Moderate
Gingival Recession, Plastic Surgery
Gingival Recession Localized Moderate
Gingival Recession, Generalized
Gingival Recession, Localized
Gingival Recession, Mucogingival Surgery
Gingival Recessions
First Posted Date
2025-09-08
Last Posted Date
2025-09-16
Lead Sponsor
University Hospital, Ghent
Target Recruit Count
34
Registration Number
NCT07158528
Locations
🇧🇪

Department of Periodontology and Implantology of Ghent University, Ghent, Oost-Vlaanderen, Belgium

Characterization of EVs (Extracellular Vesicles)/miRNAs (microRNAs) From Human Follicular Fluid

Not Applicable
Not yet recruiting
Conditions
Extracellular Vesicles
First Posted Date
2025-08-29
Last Posted Date
2025-08-29
Lead Sponsor
University Hospital, Ghent
Target Recruit Count
14
Registration Number
NCT07148284
Locations
🇧🇪

Ghent University Hospital, Ghent, Belgium

Accelerated rTMS in Hospitalized Patients With OCD: a Feasibility and Mechanistic Study

Not Applicable
Recruiting
Conditions
Obsessive - Compulsive Disorder
First Posted Date
2025-08-22
Last Posted Date
2025-08-22
Lead Sponsor
University Hospital, Ghent
Target Recruit Count
60
Registration Number
NCT07135414
Locations
🇧🇪

UZ Gent, Ghent, Oost-Vlaanderen, Belgium

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 129
  • Next

News

Virometix Completes Enrollment in Phase I Trial of V-212 Synthetic Pneumococcal Vaccine

Virometix AG has successfully completed enrollment of 60 healthy subjects aged 18-45 years in its Phase I clinical trial of V-212, a fully synthetic, serotype-independent vaccine candidate targeting Streptococcus pneumoniae infections.

Osivax Completes Phase 2a Booster Trial for Broad-Spectrum Influenza Vaccine OVX836

Osivax announced completion of patient visits in its Phase 2a booster trial evaluating OVX836, a broad-spectrum influenza A vaccine candidate targeting the highly conserved nucleoprotein antigen.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.